Gillian C. Ivers-Read
2015
In 2015, Gillian C. Ivers-Read earned a total compensation of $2.3M as EVP of Technical Operations and Chief Regulatory Officer at Clovis Oncology, a 40% decrease compared to previous year.
Compensation breakdown
| Bonus | $61,182 |
|---|---|
| Option Awards | $1,782,102 |
| Salary | $410,000 |
| Other | $26,423 |
| Total | $2,279,707 |
Ivers-Read received $1.8M in option awards, accounting for 78% of the total pay in 2015.
Ivers-Read also received $61.2K in bonus, $410K in salary and $26.4K in other compensation.
Rankings
In 2015, Gillian C. Ivers-Read's compensation ranked 4,225th out of 13,638 executives tracked by ExecPay. In other words, Ivers-Read earned more than 69.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,225 out of 13,638 | 69th |
Division Manufacturing | 1,548 out of 5,190 | 70th |
Major group Chemicals And Allied Products | 564 out of 1,854 | 70th |
Industry group Drugs | 447 out of 1,528 | 71st |
Industry Pharmaceutical Preparations | 352 out of 1,182 | 70th |
Source: SEC filing on April 26, 2017.
Ivers-Read's colleagues
We found five more compensation records of executives who worked with Gillian C. Ivers-Read at Clovis Oncology in 2015.
2015
Patrick Mahaffy
Clovis Oncology
Chief Executive Officer
2015
Andrew Allen
Clovis Oncology
Chief Medical Officer
2015
Lindsey Rolfe
Clovis Oncology
Chief Medical Officer
2015
Erle Mast
Clovis Oncology
Chief Financial Officer
2015
Steven Hoerter
Clovis Oncology
EVP and Chief Commercial Officer
News
Clovis Oncology CEO Patrick Mahaffy's 2021 pay slips 18% to $2.6M
April 27, 2022
Clovis Oncology CEO Patrick Mahaffy's 2020 pay falls 53% to $3.2M
April 28, 2021
Clovis Oncology CEO Patrick Mahaffy's 2019 pay rises 10% to $6.9M
April 24, 2020
Clovis Oncology CEO Patrick Mahaffy's 2018 pay falls 28% to $6.3M
April 26, 2019